期刊文献+

COPD急性加重期合并2型糖尿病吸入舒利迭粉对血糖的影响 被引量:2

原文传递
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)急性加重期合并2型糖尿病患者吸入舒利迭(沙美特罗替卡松)粉对血糖的影响。方法入选60例患者常规治疗基础上加用沙美特罗替卡松粉吸入,比较吸入前、后糖化血红蛋白(HbAlc),晨8时空腹血糖(8AMFPG)、餐后2小时血糖(2hPG)的变化。结果吸入治疗10d后患者HbAlc、8AMFPG、2hPG与吸入前比较差异均无统计学意义(P>0.05)。结论 COPD患者急性加重期合并2型糖尿病患者使用沙美特罗替卡松粉吸入不会对血糖造成明显影响。
作者 文燕
出处 《中华全科医学》 2010年第12期1546-1547,共2页 Chinese Journal of General Practice
  • 相关文献

参考文献8

  • 1Celli BR,Macn Nee W. Standards for diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper[ J ]. Eur Respir J,2004,231932-946.
  • 2慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103
  • 3-.WHO专家咨询报告.关于糖尿病的诊断标准与分型[J].中国糖尿病杂志,2000,1:5-5.
  • 4王烨,徐卫国,罗勇.慢性阻塞性肺疾病支气管舒张试验47例临床分析[J].中国实用内科杂志,2008,28(12):1025-1027. 被引量:9
  • 5Balbi B, Majori M, Bertaccos S, et al. Inhaled corticosteroids in stable COPD patient do they have effects on cell and molecular medintors of airway inflammation [ J ]. Ches,2000,117 (6) : 1633 -1637.
  • 6Szafransi W, Cukier A, Rami.rez A, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disese[ J]. EurRespir J,2003,21 ( 1 ) :74.
  • 7Maltais F, Ostinelli J, Bourbeau J,et al. Comparison of nebulized budes- onide and oral prednisolone with placebo the treatment of acute exacer- bations of chronic obstructive pulmonary disease: a randomized controlled trial[J]. Am J Respir Crit Med,2002,165:698-703.
  • 8李光伟.SARS治疗中应用糖皮质激素致糖尿病危险应予以重视[J].中华内分泌代谢杂志,2004,20(1):1-2. 被引量:37

二级参考文献11

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
  • 2Orozco-Levi M, Garcia-Aymerich J, Villar J, et al. Wood smoke exposure and risk of chronic obstructive pulmonary disease [ J ]. Eur Respir J ,2006,27:542 - 546.
  • 3Van Overveld FJ, Demkow U, Goreka D, et al. Differences in responses upon corticosteroid therapy between smoking and nonsmoking patients with COPD [ J ]. J Physiol Pharmacol, 2006,57 : 273 - 282.
  • 4Wagena EJ,Knipschild P,Huibers MJH,et al. The efficacy of bupropion and nortiptyline for smoking cessation among people who are at risk for or have chronic obstructive pulmanory disease : a randomized placebo-controUed trial [ J ]. Arch Int Med, 2005,165 : 2286 - 2292.
  • 5Renkema TE, Kerstjens HA, Schouten JP, el al. The importance of serum IgE for level and longitudinal change in airways hyperresponsiveness in COPD [ J ~. Clin Experim Allergy, 1998, 28 : 1210 -1218.
  • 6Sarah AL, Lan DP, Stnger JR, et al. Relation between peripheral blood leukocyte counts and respiratory symptoms atopy lung function and airway responsiveness in adults [ J ]. Chest, 2001,119: 105 - 114.
  • 7Winter JE, Wilson AM, Winter JH, et al. Predictors for admission to hospital in patients with chronic obstructive pulmonary disease [J]. Eur Respir J ,2004,24:662s.
  • 8Wilkinson TM, Hurst JR, Perare WR, et al. exacerbations of COPD: relationship between presenting symptoms and outcome [ J]. Eur Respir J ,2004,24:63s.
  • 9柳洁,秦洁,邵晋康,薛雪华,苗芳,杨艳兰.糖尿病合并SARS的临床特点及救治体会[J].中华内分泌代谢杂志,2004,20(1):3-5. 被引量:4
  • 10郑宝忠,何庆,逄崇杰,冯凭.61例SARS患者血糖分析[J].中华内分泌代谢杂志,2004,20(1):6-8. 被引量:4

共引文献5145

同被引文献16

  • 1李冬祎,陈颖.慢性阻塞性肺疾病合并糖尿病患者肺功能的变化[J].首都医科大学学报,2007,28(4):542-544. 被引量:19
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
  • 3中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010版)[M].北京:北京大学医学出版社,2010:5.
  • 4Konstantikaki V, Kostikas K, Minas M, et al. Comparison of a network of primary care physicians and an open spirometry programme for COPD diagnosis [ J ]. Respir Med,2011,105 ( 2 ) : 274-281.
  • 5Ansari K, Shamssain M, Farrow M, et al. Hospital-at-home care for ex- acerbations of chronic obstructive pulmonary disease : an observational cohort study of patients managed in hospital or by nurse practitioners in the community[J]. Chron Respir Dis,2009,6(2) :69-74.
  • 6Bourbeau J,van der Palen J. Promoting effective self-management pro- grammes to improve COPD [J]. Eur Respir J,2009,33 ( 3 ) :461-463.
  • 7Sin DD, MeAlister FA,Paul Man SF, et al. Contemporary management of chronic obstructive pulmonary disease : scientific review [ J ]. JAMA, 2003,290(17) :2301-2312.
  • 8Hogg JC, Chu F, Utokapareh S, et al. The nature of small-airway ob- struction in chronic obstructive pulmonary disease [ J ]. N Engl J Med, 2004,350 ( 26 ) : 2645-2653.
  • 9Tkacova R, Toth S, Sin DD. Inhaled corticosteroids and survival in COPD patients receiving long-term home oxygen therapy [ J ]. Respir Med ,2006,100 ( 3 ) :385-392.
  • 10Suissa S. Effectiveness of inhaled corticosteroids in chronic obstruc- tive pulmonary disease: immortal time bias in observational studies [ J ]. Am J Respir C rit Care Med ,2003,168 (1) :49-53.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部